These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34843205)

  • 1. Simultaneous, Single-Particle Measurements of Size and Loading Give Insights into the Structure of Drug-Delivery Nanoparticles.
    Kamanzi A; Gu Y; Tahvildari R; Friedenberger Z; Zhu X; Berti R; Kurylowicz M; Witzigmann D; Kulkarni JA; Leung J; Andersson J; Dahlin A; Höök F; Sutton M; Cullis PR; Leslie S
    ACS Nano; 2021 Dec; 15(12):19244-19255. PubMed ID: 34843205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polydispersity characterization of lipid nanoparticles for siRNA delivery using multiple detection size-exclusion chromatography.
    Zhang J; Haas RM; Leone AM
    Anal Chem; 2012 Jul; 84(14):6088-96. PubMed ID: 22816783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemistry of Lipid Nanoparticles for RNA Delivery.
    Eygeris Y; Gupta M; Kim J; Sahay G
    Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved multidetector asymmetrical-flow field-flow fractionation method for particle sizing and concentration measurements of lipid-based nanocarriers for RNA delivery.
    Mildner R; Hak S; Parot J; Hyldbakk A; Borgos SE; Some D; Johann C; Caputo F
    Eur J Pharm Biopharm; 2021 Jun; 163():252-265. PubMed ID: 33745980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the heterogeneity level in lipid nanoparticles for siRNA delivery: size-based separation, compositional heterogeneity, and impact on bioperformance.
    Zhang J; Pei Y; Zhang H; Wang L; Arrington L; Zhang Y; Glass A; Leone AM
    Mol Pharm; 2013 Jan; 10(1):397-405. PubMed ID: 23210488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA.
    Chen S; Tam YYC; Lin PJC; Sung MMH; Tam YK; Cullis PR
    J Control Release; 2016 Aug; 235():236-244. PubMed ID: 27238441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of siRNA-Loaded Lipid Nanoparticles using a Microfluidic Device.
    Maeki M; Okada Y; Uno S; Niwa A; Ishida A; Tani H; Tokeshi M
    J Vis Exp; 2022 Mar; (181):. PubMed ID: 35404350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA.
    Kulkarni JA; Darjuan MM; Mercer JE; Chen S; van der Meel R; Thewalt JL; Tam YYC; Cullis PR
    ACS Nano; 2018 May; 12(5):4787-4795. PubMed ID: 29614232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization of Ostwald ripening in low molecular weight amino lipid nanoparticles for systemic delivery of siRNA therapeutics.
    Gindy ME; Feuston B; Glass A; Arrington L; Haas RM; Schariter J; Stirdivant SM
    Mol Pharm; 2014 Nov; 11(11):4143-53. PubMed ID: 25317715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusion-dependent formation of lipid nanoparticles containing macromolecular payloads.
    Kulkarni JA; Witzigmann D; Leung J; van der Meel R; Zaifman J; Darjuan MM; Grisch-Chan HM; Thöny B; Tam YYC; Cullis PR
    Nanoscale; 2019 May; 11(18):9023-9031. PubMed ID: 31021343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery.
    Maeki M; Uno S; Niwa A; Okada Y; Tokeshi M
    J Control Release; 2022 Apr; 344():80-96. PubMed ID: 35183654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration.
    Chen S; Tam YY; Lin PJ; Leung AK; Tam YK; Cullis PR
    J Control Release; 2014 Dec; 196():106-12. PubMed ID: 25285610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insight into mechanisms of cellular uptake of lipid nanoparticles and intracellular release of small RNAs.
    Yu B; Wang X; Zhou C; Teng L; Ren W; Yang Z; Shih CH; Wang T; Lee RJ; Tang S; Lee LJ
    Pharm Res; 2014 Oct; 31(10):2685-95. PubMed ID: 24740244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Microfluidic-Based Post-Treatment Process for Size-Controlled Lipid Nanoparticles and Application to siRNA Delivery.
    Kimura N; Maeki M; Sato Y; Ishida A; Tani H; Harashima H; Tokeshi M
    ACS Appl Mater Interfaces; 2020 Jul; 12(30):34011-34020. PubMed ID: 32667806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of lipid nanoparticles by Cryo-EM for characterizing siRNA delivery vehicles.
    Crawford R; Dogdas B; Keough E; Haas RM; Wepukhulu W; Krotzer S; Burke PA; Sepp-Lorenzino L; Bagchi A; Howell BJ
    Int J Pharm; 2011 Jan; 403(1-2):237-44. PubMed ID: 20974237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of Peptidomimetic Functionalized Cholesterol Based Lipid Nanoparticles for Efficient Delivery of Therapeutic Nucleic Acids.
    Ehexige E; Ganbold T; Yu X; Han S; Baigude H
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31546908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Lipid Nanoparticles Containing Ionizable Cationic Lipids Using Design-of-Experiments Approach.
    Terada T; Kulkarni JA; Huynh A; Chen S; van der Meel R; Tam YYC; Cullis PR
    Langmuir; 2021 Jan; 37(3):1120-1128. PubMed ID: 33439022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective detection and characterization of nanoparticles from motor vehicles.
    Johnston MV; Klems JP; Zordan CA; Pennington MR; Smith JN;
    Res Rep Health Eff Inst; 2013 Feb; (173):3-45. PubMed ID: 23614271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver.
    Zhang R; El-Mayta R; Murdoch TJ; Warzecha CC; Billingsley MM; Shepherd SJ; Gong N; Wang L; Wilson JM; Lee D; Mitchell MJ
    Biomater Sci; 2021 Feb; 9(4):1449-1463. PubMed ID: 33404020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major difference in particle size, minor difference in release profile: a case study of solid lipid nanoparticles.
    Huang Z; Wu L; Wang W; Wang W; Fu F; Zhang X; Huang Y; Pan X; Wu C
    Pharm Dev Technol; 2021 Dec; 26(10):1110-1119. PubMed ID: 34694203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.